Tag: cancer
-
Novartis Licenses Biomaterial for Cancer Immunotherapy
Drug maker Novartis is licensing from a lab at Harvard University a biocompatible material designed to provide delivery of treatments that invoke the immune system to fight cancer.
-
More Accurate Thyroid Cancer Screening Technology Advances
A European initiative is developing a laser-enhanced technology to better distinguish between cancerous and benign thyroid nodules, for catching thyroid cancer earlier as well as preventing unnecessary surgeries.
-
Cancer Drug Seen to Reverse Autism Spectrum Symptoms
Small doses of a drug for blood-related cancers are shown in lab mice to reverse social symptoms often found in children with autism spectrum disorder, a condition characterized by limited social activity.
-
Boron Radiation Therapy Company Forms with $40M Funding
A start-up enterprise, spun off from a fusion energy company, plans to develop radiation therapies for solid tumor cancers often considered difficult to treat with conventional methods.
-
A.I. Shown to Boost Cancer Clinical Trial Enrollment
Early results from a system using a supercomputer and artificial intelligence to match breast cancer patients to clinical trials shows faster screening and higher enrollment rates in these studies compared to manual methods.
-
Peptide Hydrogel Boosts Cancer Immunotherapies
A team at Rice University in Houston developed an injectable gel material that in lab mice slows the release of cancer immunotherapy drugs, enhancing the treatments’ effectiveness and reducing the need for repeated doses.
-
Company Formed to Develop Cancer Cell Therapies
The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells.
-
FDA Clears Consumer Genetic Breast Cancer Risk Tests
The Food and Drug Administration authorized the first direct-to-consumer tests of genetic risk for cancer, in this case 3 variations of genes associated with higher risk of breast and ovarian cancer.
-
3-D Biomaterial Boosts Personal Cancer Immunotherapy
A Harvard University bioengineering lab developed an injectable material designed to load up with proteins from a patient’s own tumors to induce immune reactions that fight that person’s cancer.
-
Breathalyzer Biopsy Company Gains $15M in New Funds
A company in the U.K. developing a technology for early and precise diagnosis of lung and other cancers by analyzing exhaled breath is raising $15 million in new venture capital.